Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sustained-release dosage forms of ruxolitinib

Sustained-release dosage forms of ruxolitinib

US Patent 11576865 · Granted Feb 14, 2023

Estimated economic value: $51,998,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dosing regimen for the treatment of PI3K related disorders2025
Topical formulation for a JAK inhibitor2025
Topical formulation for a JAK inhibitor2025
User context-based enterprise search with multi-modal interaction2024
JAK1 pathway inhibitors for the treatment of gastrointestinal disease2024
Sustained release dosage forms for a JAK1 inhibitor2024
Sustained release dosage forms for a JAK1 inhibitor2024
Multiple semantic hypotheses for search query intent understanding2024
Sustained-release dosage forms of ruxolitinib2024
Sustained-release dosage forms of ruxolitinib2024
Sustained-release dosage forms of ruxolitinib2024
Sustained-release dosage forms of ruxolitinib2024